Literature DB >> 17100828

Ovarian sclerosing stromal tumor presenting as Meigs' syndrome with elevated CA-125.

Nan Hee Jung1, Tak Kim, Hai Joong Kim, Kyu Wan Lee, Nak Woo Lee, Eung Seok Lee.   

Abstract

Meigs' syndrome caused by sclerosing stromal tumor is extremely rare and only two cases have been reported to date. An elevated serum level of CA-125 is also unusual and it has been thought that it is the consequence of physical irritation and inflammation. In this report, we present the case of a 50-year-old postmenopausal woman with a sclerosing stromal tumor presenting with Meigs' syndrome and an elevated CA-125 level (1476.8 IU/mL). This case highlights the difficulty in discerning the diagnosis of Meigs' syndrome from that of an ovarian malignancy and it should be considered in the differential diagnosis in postmenopausal patients with pelvic mass, ascites, pleural effusions and elevated serum CA-125.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17100828     DOI: 10.1111/j.1447-0756.2006.00466.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  Sclerosing stromal tumor of the ovary with atypical magnetic resonance imaging findings in a middle-aged woman.

Authors:  Hiroko Wada; Akihito Mitsumori; Tsuyoshi Hyoudou; Shinnichirou Matsubara; Michinori Yamamoto; Masayoshi Fujisawa; Nobuo Akamatsu; Susumu Kanazawa
Journal:  Jpn J Radiol       Date:  2009-07-22       Impact factor: 2.374

2.  Sclerosing stromal cell tumor of ovary.

Authors:  Shazia Khan; Virendra Singh; I D Khan; Sujatha Panda
Journal:  Med J Armed Forces India       Date:  2017-12-02

3.  Sclerosing stromal tumour of the ovary: A case report and the review of literature.

Authors:  Ozhan Ozdemir; Mustafa Erkan Sarı; Ertuğrul Sen; Aslıhan Kurt; Ayşe Burce Ileri; Cemal Reşat Atalay
Journal:  Niger Med J       Date:  2014-09

4.  Ovarian fibroma/fibrothecoma with elevated serum CA125 level: A cohort of 66 cases.

Authors:  Yuanming Shen; Yun Liang; Xiaodong Cheng; Weiguo Lu; Xing Xie; Xiaoyun Wan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.